(Q39438457)

English

The immunomodulatory drug lenalidomide restores a vitamin D sensitive phenotype to the vitamin D resistant breast cancer cell line MDA-MB-231 through inhibition of BCL-2: potential for breast cancer therapeutics.

scientific article

Statements

The immunomodulatory drug lenalidomide restores a vitamin D sensitive phenotype to the vitamin D resistant breast cancer cell line MDA-MB-231 through inhibition of BCL-2: potential for breast cancer therapeutics. (English)
0 references
0 references
0 references
Carole Brosseau
Kay Colston
Angus George Dalgleish
Christine Galustian
1 February 2012
164-173

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit